The quest for the Holy Grail of tissue factor pathway inhibitor deficiency has just begun
- 1 April 2005
- journal article
- editorial
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 3 (4) , 649-650
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI)Journal of Thrombosis and Haemostasis, 2005
- The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery diseaseClinical Biochemistry, 2005
- Potential of free-form TFPI and PAI-1 to be useful markers of early atherosclerosis in a Japanese general population (the Suita Study): association with the intimal-medial thickness of carotid arteriesAtherosclerosis, 2004
- Involvement of Tissue Factor Pathway Inhibitor in the Coronary Circulation of Patients With Acute Coronary SyndromesCirculation, 2003
- Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosisBlood, 2003
- Poor anticoagulant response to tissue factor pathway inhibitor in patients with venous thrombosisJournal of Thrombosis and Haemostasis, 2003
- Lethal Perinatal Thrombosis in Mice Resulting From the Interaction of Tissue Factor Pathway Inhibitor Deficiency and Factor V LeidenCirculation, 2002
- Analysis of the tissue factor pathway inhibitor gene and antigen levels in relation to venous thrombosisBritish Journal of Haematology, 2001
- Low Levels of Heparin-releasable Tissue Factor Pathway Inhibitor in Young Patients with ThrombosisThrombosis and Haemostasis, 1999
- Inherited Thrombophilia: Part 1Thrombosis and Haemostasis, 1996